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Background: The human APOBEC3G (A3G) protein activity is associated with innate immunity against HIV-1 by
inducing high rates of guanosines to adenosines (G-to-A) mutations (viz., hypermutation) in the viral DNA. If
hypermutation is not enough to disrupt the reading frames of viral genes, it may likely increase the HIV-1 diversity.
To counteract host innate immunity HIV-1 encodes the Vif protein that binds A3G protein and form complexes to
be degraded by cellular proteolysis.
Methods: Here we studied the pattern of substitutions in the vif gene and its association with clinical status of
HIV-1 infected individuals. To perform the study, unique vif gene sequences were generated from 400
antiretroviral-naïve individuals.
Results: The codon pairs: 78–154, 85–154, 101–157, 105–157, and 105–176 of vif gene were associated with CD4+ T
cell count lower than 500 cells per mm3. Some of these codons were located in the 81LGQGVSIEW89 region and
within the BC-Box. We also identified codons under positive selection clustered in the N-terminal region of Vif
protein, between 21WKSLVK26 and 40YRHHY44 regions (i.e., 31, 33, 37, 39), within the BC-Box (i.e., 155, 159) and the
Cullin5-Box (i.e., 168) of vif gene. All these regions are involved in the Vif-induced degradation of A3G/F complexes
and the N-terminal of Vif protein binds to viral and cellular RNA.
Conclusions: Adaptive evolution of vif gene was mostly to optimize viral RNA binding and A3G/F recognition.
Additionally, since there is not a fully resolved structure of the Vif protein, codon pairs associated with CD4+ T cell
count may elucidate key regions that interact with host cell factors. Here we identified and discriminated codons
under positive selection and codons under functional constraint in the vif gene of HIV-1.
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The APOBEC (apolipoprotein B mRNA-editing catalytic
polypeptide) gene family includes several members,
APOBEC1, APOBEC2, APOBEC3 and APOBEC4 that
have cytidine deaminase activity [1-3]. Notably, two
genes of APOBEC3 (APOBEC3G and APOBEC3F) have
been linked to innate immunity, and their ability to
restrain retroviral infections has been widely recognized
[4,5]. APOBEC3G (A3G) induces cytidine deamination
(C→U) in the negative strand of HIV-1 during reverse
transcription, hence inducing substitutions of guanosines
for adenosines (G→A) in the positive strand of the viral* Correspondence: elcioleal@gmail.com
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reproduction in any medium, provided the orDNA. This mechanism is known as hypermutation and
may cause the appearance of stop codons followed by
the complete loss of reading frames of the viral genes.
HIV-1 counteracts A3G activity through ubiquitination
of this host protein through the activity of Vif proteins.
Vif proteins assemble with viral-specific E3 ubiquitin ligase
through its interaction with cellular Cullin5 (Cul5)-
ElonginB-ElonginC proteins, inducing ubiquitination of
A3G and consequent degradation by the proteasomal
complex [6-10]. Hypermutation is not enough to curb
HIV-1 infection because proviruses with varying amounts
of G→A mutations are commonly observed in the host
genome [11-13]. Furthermore, the polymorphisms in
the vif gene have been associated with more or less
efficacy to neutralize A3G [5]. For these reasons, it hasl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ive in neutralizing viral genomes, the side effect is that A3G
can actually promote HIV-1 diversification [14,15].
The interaction between the cellular A3G and the
vif gene of HIV likely emerged from a process of co-
adaptation due to recurrent retroviral infections during the
evolutionary history of primates [2,16]. Specifically, the
repeated encounters with retroviruses probably promoted
the fixation of the allelic variants in the genes of the human
family of the APOBEC [17-20].
Recently, we found that A3G polymorphisms are
mostly unrelated with CD4+ T cell counts of HIV-1
infected Brazilians [21]. Thus, population-based studies
may provide conflicting results regarding the overall
effect of A3G-vif interactions [5,21-23]. To gain more
insights on the A3G-HIV interaction, we used codon-based
approaches to determine the function of amino acid substi-
tutions of Vif protein. The study was made through the
analysis of 400 vif gene sequences obtained from HIV-1
infected drug-naïve individuals.
Methods
HIV-1 infected individuals
This study was approved by the Ethics Committee of the
Federal University of São Paulo and by the Brazilian
Ministry Health; all biological samples were obtained in
full accordance with signed informed consent forms.
DNA samples
Proviral DNA was extracted from heparinized peripheral
blood obtained from 400 HIV-1 infected individuals that
were drug-naïve (not receiving any antiretroviral therapy)
and asymptomatic when samples were collected. From
each patient one unique sequence of HIV-1 vif gene was
generated, then our study focused on the diversity of the
virus at the population level. The study group represented
almost equally the male (55.5%) and female (45.5%) popu-
lations and was composed of three ethnics groups: white
(49.2%), mulatto (41.6%) and black (9.2%) individuals. The
CD4 counts (cells/mm3) ranged from 20 to 5362 and the
virus load ranged from 80 to 7.8 x 107 (RNA copies/ml of
plasma). HIV-1-infected individuals sampled from São
Paulo city between 1989 and 2006 comprised our target
population. These individuals were enrolled in the AIDS
program of the Brazilian Ministry of Health.
PCR and sequencing of the vif gene of HIV-1
The vif sequence was amplified by a nested PCR. The
primers were designed to cover the entire vif gene,
according to the reference sequence HXB2 (HIV Sequence
Database). The first round was performed with the primers,
Platinum Taq DNA Polymerase, 10X Reaction Buffer,
MgCl2 (Invitrogen, USA) and deoxyribonucleotide triphos-
phates (dNTP; GE Healthcare, USA). The second-roundPCR was carried out using 5 μl of the first-round product
and internal primers. Amplified vif DNA was purified and
then sequenced using the BigDye Terminator kit, version
3.1 (Applied Biosystems/Perkin Elmer, Foster City, CA).
The samples were electrophoresed on an ABI 3130 genetic
analyzer, and the sequencing data were analyzed using ABI
software Sequencing Analysis Software.
Sequences Analysis. Nucleotide and protein sequence
analyses and edits were performed using the
Sequencher DNA Sequence Assembly Software (Gene
Codes Corporation, USA).
Hypermutation detection in the integrase gene of HIV-1
We used a previously described approach to detect the
presence of hypermutation in the PCR products of the
integrase gene of HIV-1 [24]. Briefly, the PCR products
were initially analyzed on 1% agarose gels to confirm
amplification. After that, a second electrophoresis was
performed with HA yellow (9 μL/mL) incorporated into
the agarose gel solution at 65°C and pH 7.5. The electro-
phoresis was performed at 80 V in 0.5× Tris-borate-EDTA
(TBE) for 150 min. The HA yellow gel was visualized
after immersion in a solution of ethidium bromide,
using the Geldoc-it TS Imaging Systems BioImaging
(UVP, Cambridge, CA, EUA). HA yellow is a compound
consisting of the DNA ligand, bisbenzamide, covalently
linked to polyethylene glycol (PEG) (Resolve-It Kit - Vector
Laboratories, Burlingname, CA, USA). Bisbenzamide binds
preferentially to AT-rich regions in the DNA and, when
coupled to PEG, retards DNA mobility during gel elec-
trophoresis according to the AT content. We used three
distinct samples that independently amplified as negative
(no hypermutation) and positive controls (hypermutated).
The hypermutation statuses of the controls were confirmed
by bacterial cloning followed by sequencing.
Sequence alignment and phylogenetic inference
Initially, the sequences of the vif gene of HIV-1 were
aligned using the ClustalX program [25]. Sequences
with stop codons and hypermutations were excluded
from the analyses. We used the Hypermut software
(http://www.hiv.lanl.gov/content/sequence/HYPERMUT/
hypermut.html).
After this editing process, the sequences were manually
aligned using the SE-AL program, version 2.0 (Department
of Zoology, Oxford University; http://evolve.zoo.ox.ac.uk/
software/). To construct maximum likelihood (ML) trees,
we used the HKY model [26], as implemented in the
PhyML software [27]. These trees were used mainly to the
selective regimen analysis.
Association of HIV vif gene and CD4+ cell counts
We investigated whether individual codons or pairs of
codons in vif gene were associated with levels of CD4+
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tests were used. The log-transformed CD4 counts were
regressed on the amino acids or amino acid pairs. To
account for multiplicity, we generated 1000 sets of
samples under the null hypothesis of no association by
permuting the CD4+T counts. The p-values obtained by
the log likelihood ratio statistics were contrasted with the
null distribution of minimum p-values among amino acid
positions with SNPs and pairs of these positions.
Covariation among codons based on phylogenies
A Bayesian Graph method (BGM) was used to explore
covariation among amino acids in codons of the vif gene
taking into account the phylogenetic information of the
sequences [28]. Therefore, BGM considers the potential
bias due to the founder effect and relaxes the assumption
of pairwise associations. BMG reconstructs the maximum
likelihood of evolutionary history of the extant sequences,
and then it analyzes the joint probability distribution of
substitution events among sites in the sequences through
a Bayesian graph model. The method was used to detect
co-evolving sites in vif. The analyses were performed
assuming a GTR model [29], and sites with a marginal
posterior probability of 0.85 were considered to be under
epistasis. The analysis was performed on the Datamonkey
web server (http://www.datamonkey.org).
Detection of selective pressure
We used a codon-based maximum likelihood method to
estimate the selection pressures of the vif sequences.
This approach estimates the likelihood of distinct models of
codon evolution and computes the ratio (dN/dS=ω) of the
number of nonsynonymous (dN) and synonymous (dS) sub-
stitution rates between sites considering the phylogenetic
relationships of the sequences.
The nonsynonymous/synonymous rate ratio (ω) de-
termines selective pressures at protein level. When
selection (neutral) has no effect on the fitness the
nonsynonymous and the synonymous mutations will
occur at the same rates (dN=dS).
Situations where nonsynonymous mutations are dele-
terious, negative (purifying) selection will reduce their
rate of fixation (dN<dS). If nonsynonymous mutations
raise the fitness, their rate will be increased by positive
selection (dN>dS).
We used the following codon models. The one-ratio
model (M0) assumes a single ω for all sites in the
alignment and is the simplest model. The neutral model
(M1) allows for different proportions of conserved sites
(ω0=0) and neutral sites (ω1=1), both estimated from the
data. Model 1 is the null hypothesis to test for positive
selection. The selection model (M2) extends M1 and
incorporates an additional class of sites with ω ratios
assuming values higher than one (ω2 > 1). Significantevidence for positive selection is provided if M2 signifi-
cantly reject the null hypotheses, M0 and M1, and if the
favored models contain a class of codons with ω > 1.
Statistical significance can be compared using a standard
likelihood ratio test (LRT). These models are implemented
in the CODEML program from the PAML v.4 package
(http://abacus.gene.ucl.ac.uk/software/paml.html) [30].
Results
Diversity of vif gene
To characterize the sequences of the HIV-1 vif gene
from Brazilians, we analyzed the nucleotide and amino
acid substitutions on a site-by-site basis. The overall
nucleotide distance of 235 subtype B isolates in the
alignment of 581 nucleotides was 0.031±0.004. The
translated Vif sequence of 192 amino acids identified 22
singletons, 53 conserved and 138 variable sites. In general
the amino acid composition was relatively conserved
among subtypes in Brazil and all regions with biological
functions were equally conserved. The genetic diversity
was estimated assuming the HKY85 model and the analysis
were performed using Mega 4.0 software [31].
Pairs of codons in vif gene associated with CD4+ cells
The regression analysis indicated that no single amino
acid positions in vif gene were significantly associated
with the CD4+T counts. However, when we analyzed the
impact of pairs of codons in the levels of CD4+T cells,
the epistatic effects of five pairs of amino acids (i.e., 78–
154, 85–154, 101–157, 105–157, and 105–176 pairs) were
detected at a 5% significance level after correction for
multiplicity (orange dashed lines in the Figure 1). Notably,
most combinations of amino acids in these epistatic sites
tend to be associated with CD4+ T cell counts below 500
cells per mm3 (see Figure 2 for a detailed description of
pairs of residues and their correlation with CD4 counts).
We used a proposed three-dimensional computational
model of Vif [32] (PDB: 1VZF) to shown the location of
the pairs of epistatic codons on the structure of this viral
protein (Figure 3).
Coevolving sites in the vif gene
By using a posterior probability of 0.85, the BGM analysis
detected three pairs of codons (i.e., 80–83, 80–86 and
83–144) where amino acids were coevolving in vif gene.
These sites were not the same epistatic sites identified
by regression/permutation, although they were concen-
trated in a specific genomic region of vif between sites
78 to 86 and within the BC-box (see blue dashed lines
in the Figure 1 and magenta dotted lines in the Figure 3).
However when we reduced the threshold of the posterior
distribution to 0.5, various other sites were indicated
to be under epistasis, including those identified by the
permutation analysis.
Figure 1 Consensus sequences of the vif gene of HIV-1. The consensus was obtained from an alignment of 71 sequences containing only subtype
B viruses. Open and filled diamonds indicate sites under positive selection. The figure shows positively selected codons detected in non-recombinant
(filled diamonds) sequences and detected in hypermutated viruses (open diamonds). The regions linked to Vif protein functions are highlighted in dark
grey with white letters within. The BC-Box and the Cullin5-Box are also highlighted (yellow). Dashed grey lines mark regions where cytotoxic T
lymphocytes (CTL) epitopes were previously identified in the Vif protein (http://www.hiv.lanl.gov/content/immunology/maps/maps.html). Orange ovals
linked by dashed lines indicate epistatic sites associated with CD4+ cell counts detected by permutation test. Blue circles linked by dashed lines indicate
co-evolving sites detected by BGM analysis.
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To explore the selective regimen acting on the vif gene
of the subtype B lineage of Brazilian isolates, we used a
codon-based model to estimate the dN/dS ratio. Recom-
bination affects the reliability of likelihood ratio test
(LRT) to discriminate models of positive selection [33],
then we decided to analyze selective forces in vif
sequences that have not recombined. To do that we used
a Bayesian approach [34] to identify recombination-free
sequences. These sequences were compiled in a data set
composed of seventy-one (n=71) recombination-free iso-
lates that were edited in order to exclude sequences with
stop codons. The estimated likelihoods of model M2
(−l=6882.348) indicated that the hypothesis of positive
selection in the evolution of the vif gene was effectively
accepted to the detriment of the null hypothesis of neu-
tral evolution based on the likelihood of the M1 model
(−l=6985.462) (χ2=206.2277, p<0.0001, with two degree
of freedom). In detail, the M2 (selection) model detected
57.0% of codons with ω=0.049, 35.5% with ω=1.0 and
7.5% with ω=3.7. Thus, most sites of the vif gene evolved
under purifying selection. The sites under positive selec-
tion (i.e., 31, 33, 37, 39, 47, 63, 92, 127, 159 and 168)
were mapped onto the consensus of vif sequences from
the subtype B lineage (Figure 1). Positively selected sites
were distributed along the extension of the gene; codons
under positive selection were also detected within regions
that have important biological functions, such as theBC-Box and Cullin5-Box (filled diamonds in the Figure 1).
In addition, a dataset of vif sequences (n=33) from
hypermutated viruses, based on the integrase gene, was
analyzed to explore the selective regime. According to the
M2, most sites (53.6%) evolved under purifying selection
with ω=0.035, 37.2% were conserved (ω=1) codons, and
9.2% were under strong positive selection with ω=4.063.
These sites under positive selection were exactly the
same as those detected in the recombination-free data
(open diamonds in the Figure 3). Mapping positively
selected sites in the Vif protein sequence and in the 3D
structure of a computational model of Vif protein [32]
(PDB: 1VZF), revealed they were concentrated between
the 21WKSLVK26 and 40YRHHY44 motif (i.e., 31, 33, 37,
39 and 47), both important to Vif-induced degradation of
A3G/F complexes. It is important to mention that the
N-terminal region of Vif protein binds selectively to
HIV-1 genomic RNA [35] and mRNA of A3G [36]. In
addition, within the BC-Box and Cullin5-Box, we also
detected codons under high selective pressure (i.e., 155, 159
and 168) (Figure 1 and Figure 4). Positively selected sites
may indicate adaptive substitutions that usually evolve as a
consequence of the host immune response against viral
proteins. According to the Los Alamos HIV immunology
database, cytotoxic T-lymphocyte (CTL) epitopes have been
previously identified in nearly all regions of Vif protein
(http://www.hiv.lanl.gov/content/immunology/maps/maps.
html/). We then concatenated these CTL epitopes to show
Pair 101-157 Pair 105-157
Pair 105-176
Pair 78-154 Pair 85-154
Figure 2 (See legend on next page.)
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Figure 2 Epistatic codons and CD4 levels. Upper panel of each page shows the correlation between epistatic pairs and CD4+ T cell
counts. The x-axis depicts the distinct combinations of amino acids (pairs), y-axis shows the levels of CD4+ T cell counts measured as
number of cell per mm3 of plasma. Lower panel shows the location of epistatic sites (orange dots) on the structure of a computational
model (Balaji et al., Bioinformation. 2006 Dec 6;1:290-309[PMID: 17597910], PDB=1VZF) of Vif Protein of HIV-1. Yellow regions depict the
SOCS BOX (BC Box+Cullin Box) and grey regions are A3 binding sites (see text for more details). Visualization and edition of structures were
done using PyMOL software (http://www.pymol.org).
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the Figure 1). Our results indicate that the codons under
positive selection were not always located within the CTL
epitopes, whereas other CTL regions were lacking
positively selected codons. Indeed, signatures of posi-
tive selection by CTL or antibody immune pressure are
a host-specific mechanism that is rarely identified by
population-based analyses [37-39].A
C
B
Figure 3 Epistatic and co-evolving codons in the structure of Vif prot
protein of HIV-1 (PDB: 1VZF). Epistatic codons are depicted in distinct color
as magenta sticks in the structure and magenta dashed lines are connectin
in white color in the Vif structure. The BC-Box and the Cullin5-Box were hig
rotating angles of the structure of Vif.Discussion
While hypermutation induced by A3G activity is a natural
barrier against retroviruses it is not enough to restrain HIV-
1 infection. Sometimes, A3G activity can actually increase
HIV-1 diversification [14,15] because G-to-A hypermutation
is not always effective to neutralize all viral genomes within
a specific host. Our results suggest that the diversity in the
HIV-1 vif gene is highly associated with adaptation to theein. 3D structure of a computational model proposed to the Vif
s and dashed lines link codon pairs. Co-evolving codons are depicted
g them. Regions that interact with Apobec3 protein were highlighted
hlighted in yellow color. Panels A, B and C correspond to distinct
Figure 4 Positively selected codons in the structure of vif protein. Codons under positive selection were mapped in structure of Vif protein
of HIV-1. Blue spheres indicate locations of positively selected codons. Cyan area designates the BC-Box and the Cullin5-Box. Grey areas indicate
regions of Vif that bind to Apobec3 protein.
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components (i.e., elongins and A3G and A3F) to induce
APOBEC3 proteasomal degradation.
Particularly, codons under positive selection were
more concentrated in a region between the 21WKSLVK26
and 40YRHHY44 motifs (i.e., 31, 33, 37 and 39). Interest-
ingly, the N-terminal region of Vif protein binds selectively
HIV-1 genomic RNA [1] and sites in this region have
DNA/RNA binding properties and also interact with A3G/
F [35,36]. Additionally, a study showed that the charge of
amino acids located between 21WKSLVK26 and 40YRHHY44
motifs that are essential for maintaining the ability of vif
to bind A3G [40]. Furthermore, it has been shown that
the N-terminal region of Vif protein is highly structured,
in contrast to the unstructured and flexible C-terminal
[41-43]. Likely, the organized N-terminal structure of Vif
functions as a connector that binds to A3G/F proteinsand DNA/DNA molecules. On the other hand, positively
selected sites detected in the C-terminal region of Vif pro-
tein were more dispensed. They were found within the
BC-Box and Cullin-Box (i.e., 127), which both assemble
with cellular components to induce A3G proteasomal
degradation [6,43-45]. Positive selection was also detected
in the vicinity of the PPLP motif (i.e., 159), which controls
multimerization of Vif proteins [46]. We also found one
codon under positive selection (i.e., 168) in a region of Vif
protein involved in the interaction with Gag, NCp7 and
with the cellular membrane [47]. It is worth to note that
in the N-terminal region of Vif protein sites under positive
selection are clustered between the 21WKSLVK26 and
40YRHHY44 motifs whereas in the C-terminal they tend to
be dispersed (see Figure 1). Since Vif protein is highly
structured at the N-terminal region, contrasting with the
unstructured C-terminal [41,42]. Therefore the N-terminal
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the C-terminal is solvent exposed and prone to immune
recognition. Consequently adaptive evolution in vif gene
could be related with the host immune surveillance against
viral proteins. However, there are various positively selected
sites outside CTL epitope regions. Additionally, wide vif
sequence intervals in which many CTL epitopes have been
empirically detected show no evidence of positive selection.
Furthermore, selection driven by antibody evasion or host
cell adaptation is rarely detected by population-based
analysis [38,48,49]. Indeed, our results showing a distinct
pattern of distribution of positively selected sites between
N and C terminals of Vif protein mirrors the structural
organization of this viral protein. For these reasons, posi-
tive selection detected in vif codons likely emerged as an
adaptive response to optimize HIV-1 RNA recognition
and neutralization of A3G/F in the population.
The comparison of amino acids of vif sequences
revealed a limited variability in regions related with
A3G/F activity, such as the regions 14DRMR17 and
40YRHHY44, which are important for vif-induced deg-
radation of A3G [40,50]. This conservation of vif mo-
tifs may indicate a significant evolutionary constraint
that has been operating on this viral gene even among
distinct lineages. Indeed, we found that most codons
(60%) of vif gene are predominantly under purifying
selection, and perhaps this pattern is needed to pre-
serve its biological function during the viral life cycle.
Likewise, HIV-1 nef gene is similarly under strong purifying
selection [37,51]. Nevertheless, Nef is a multifunctional
protein, and this feature can be observed by its
plasticity, represented by extensive polymorphism and
amino acid length variations that can be detected both in
population samples and in the viral population within a
single individual as well.
In addition, an attempt was made to establish the
influence of the patients’ statuses on the selective regimen
of HIV-1. In a previous population-level studies, we
observed that CD4+ T cell counts higher than 200
cells/μl were associated with increased dN/dS values in
the env gene of HIV-1 subtype B [48,49,52]. For this
reason, we measured the intensity of positive selection
in the vif gene from datasets categorized into three distinct
levels of CD4 counts (>200; 200–400 and <400). We found
no difference in the mean dN/dS among these data sets
(3.65, 3.85 and 3.09 respectively).
Perhaps our most remarkable finding was the identifica-
tion of five pairs of codons (i.e., 78–154, 85–154, 101–157,
105–157, and 105–176 pairs) in the vif gene and their
association with CD4+ cell levels lower than 500 cells
per mm3. In each pair (epistatic codons) distinct amino
acids combination were associated with distinct levels of
CD4+ cells (see Figure 2 for a details). Notably, these
pairs of codons were located mainly in the C-terminalof Vif protein (see Figure 1). It has been shown that the
mutation 105QLI107 to 105AAV107 reduces the infectivity
of HIV by 2% [53]. The amino acids between the 154th
and 157th positions of the vif gene comprise the BC-box,
the region that binds cellular elongin B and C to form
complexes that trigger the ubiquitination and proteasomal
degradation of the A3G proteins [44]. Since codons 154
and 157 are located in the alpha-helix of the BC-box, it is
likely that certain amino acids in these sites may affect the
interaction with the cellular elongin B and C complex and
thereby affect the efficacy of Vif-induced A3G proteasomal
degradation. In addition, the 161PPLP164 motif is funda-
mental to vif multimerization and interaction with cellular
proteins [41,44,46]. Remarkably, proline-to-alanine substi-
tutions in the 161PPLP164 motif have no effect to the vif
structure although it decreased the ability this protein to
form oligomers [41]. These findings suggest that domains
in the C-terminal of Vif protein fold independently of each
other and the flexibility of these domains is required to
interact directly with distinct cellular counterparts [41,42].
Thus, we postulate that epistatic effect observed in pairs
of codons, indicate electrostatic interaction of certain pairs
of amino acids required to Vif activity.
The presence of co-evolving sites was further investigated
using a Bayesian graph model that explores associations
between codon sites and accounts for the phylogenetic
sign of the sequences. The results indicated that amino
acids at sites 80–83, 80–86 and 83–144 of vif co-evolve
in phylogenies constructed with vif gene of the HIV-1.
Interestingly, although both methods did not indicate
the same sites, these results corroborate the identifica-
tion of a region between sites 78 to 86 of HIV-1 vif gene
that has many sites co-evolving with codons located
within the BC-box.Conclusion
The host-virus interaction between A3G and vif are
likely to affect AIDS in many instances. Conversely, the
adaptive evolution in the HIV-1 vif gene is mainly
explained by a response optimized to neutralize A3G
activity. Co-evolution detected in some codons suggests
that regions of the Vif protein are highly constrained
and may have important function to the virus activity.
Here, we identified and discriminated codons under
positive selection and codons under functional constraint
in the vif gene of HIV-1.
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